ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Innovations at Retail Pharmacies Accelerate as Digital Competition, Health and Wellness Offerings Grow, J.D. Power Finds

More Customers Planning to Switch to Digital Retailers and Health- and Wellness-Oriented Pharmacy Organizations

With more than 258.1 million total doses of the COVID-19 vaccine1 and an estimated 40 million flu vaccinations seasonally2 dispensed at retail pharmacies, U.S. consumers have grown accustomed to—and very comfortable with—the idea of receiving health services at their local pharmacies. According to the J.D. Power 2022 U.S. Pharmacy Study,SM released today, the evolution toward health and wellness services—in addition to medication management—may be the key to the future of the retail pharmacy industry as it contends with growing threats from online retailers.

“Customers are beginning to embrace their retail pharmacy as a hub for a broad range of routine health and wellness services,” said Christopher Lis, managing director, global healthcare intelligence at J.D. Power. “This transformation is happening simultaneously with rising competition from online retailers such as Amazon, which is raising the stakes for local retail pharmacies. This is an opportunity for more retail pharmacies to innovate as a one-stop shop for routine care and to leverage data and technology to create an increasingly personalized customer experience.”

Following are some of the key findings of the 2022 study:

  • Customers are interested in routine healthcare services at their pharmacies: Among pharmacy customers who are interested in receiving routine healthcare services, 33% are interested in vision and hearing services and 27% are interested in physical exams and routine lab tests at their local retail pharmacies. However, most customers recognize their pharmacies are not currently offering these services.
  • Health and wellness service utilization associated with higher loyalty and brand advocacy: On average, 52% of customers who rely on their pharmacies for health and wellness services say they will not switch pharmacies. This compares with just 45% among those who have not used their pharmacy’s health and wellness services. Likewise, Net Promoter Scores®3 are 14 points higher when customers use health and wellness services.
  • Watch out for Amazon: Nearly two-thirds (66%) of brick-and-mortar pharmacy customers currently have an Amazon Prime account and nearly half (48%) of pharmacy customers are aware of pharmacy services offered by Amazon. To date, 14% of those who are aware of Amazon’s Pharmacy Services have used Pill Pack filled through Amazon Pharmacy. Of that group, 38% say they “definitely will” switch pharmacies in the next 12 months.
  • Mobile apps could become prescription management battleground: Among brick-and-mortar customers who use their pharmacy’s mobile app, 59% use the app to manage prescription refills and 57% use the app to view prescriptions. Overall satisfaction among those who have used their pharmacy’s mobile app six or more times in the past 12 months is 715 (on a 1,000-point scale), which is 32 points higher than among those who used the app up to five times. Frequent app users are also less likely to say they will switch pharmacy providers.

Study Rankings

Good Neighbor Pharmacy ranks highest among brick-and-mortar chain drug store pharmacies for a sixth consecutive year, with a score of 740. Health Mart (723) ranks second and Walgreens ranks third (660).

Sam’s Club ranks highest among brick-and-mortar mass merchandiser pharmacies for a seventh consecutive year, with a score of 759. Costco (749) ranks second and CVS Pharmacy inside Target (713) ranks third.

H-E-B ranks highest among brick-and-mortar supermarket pharmacies for a second consecutive year, with a score of 785. Wegmans (754) ranks second and Publix (747) ranks third.

Kaiser Permanente Pharmacy ranks highest in the mail order segment, with a score of 734. CenterWell (formerly Humana Pharmacy) (699) ranks second and OptumRx (694) ranks third.

See the rank charts for each segment at http://www.jdpower.com/pr-id/2022089.

The U.S. Pharmacy Study, now in its 14th year, was redesigned for 2022. It measures customer satisfaction with brick-and-mortar and mail order pharmacies. The 2022 study is based on responses from 12,142 pharmacy customers who filled a prescription within the past 12 months and was fielded from September 2021 through May 2022.

For more information about the U.S. Pharmacy Study, visit https://www.jdpower.com/business/resource/us-pharmacy-study.

About J.D. Power

J.D. Power is a global leader in consumer insights, advisory services and data and analytics. A pioneer in the use of big data, artificial intelligence (AI) and algorithmic modeling capabilities to understand consumer behavior, J.D. Power has been delivering incisive industry intelligence on customer interactions with brands and products for more than 50 years. The world's leading businesses across major industries rely on J.D. Power to guide their customer-facing strategies.

J.D. Power has offices in North America, Europe and Asia Pacific. To learn more about the company’s business offerings, visit JDPower.com/business. The J.D. Power auto shopping tool can be found at JDPower.com.

About J.D. Power and Advertising/Promotional Rules: www.jdpower.com/business/about-us/press-release-info

_______________

1 CDC Federal Retail Pharmacy Program for COVID-19 Vaccination https://www.cdc.gov/vaccines/covid-19/retail-pharmacy-program/index.html

2 CDS Weekly Flu Vaccination Dashboard https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-administered.html

3 Net Promoter®, Net Promoter System®, Net Promoter Score® and NPS® are registered trademarks of Bain & Company, Inc., Fred Reichheld and Satmetrix Systems, Inc.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.